Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Signature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease.

Tabibiazar R, Wagner RA, Ashley EA, King JY, Ferrara R, Spin JM, Sanan DA, Narasimhan B, Tibshirani R, Tsao PS, Efron B, Quertermous T.

Physiol Genomics. 2005 Jul 14;22(2):213-26. Epub 2005 May 3.

PMID:
15870398
2.

Hepatocyte-derived ApoE is more effective than non-hepatocyte-derived ApoE in remnant lipoprotein clearance.

Raffaï RL, Hasty AH, Wang Y, Mettler SE, Sanan DA, Linton MF, Fazio S, Weisgraber KH.

J Biol Chem. 2003 Mar 28;278(13):11670-5. Epub 2003 Jan 27.

3.

Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice.

Willner EL, Tow B, Buhman KK, Wilson M, Sanan DA, Rudel LL, Farese RV Jr.

Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1262-7. Epub 2003 Jan 21.

4.

Defining the importance of phosphatidylserine synthase 2 in mice.

Bergo MO, Gavino BJ, Steenbergen R, Sturbois B, Parlow AF, Sanan DA, Skarnes WC, Vance JE, Young SG.

J Biol Chem. 2002 Dec 6;277(49):47701-8. Epub 2002 Oct 1.

5.

Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons.

Huang Y, Liu XQ, Wyss-Coray T, Brecht WJ, Sanan DA, Mahley RW.

Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8838-43. Epub 2001 Jul 10.

7.

Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat.

Smith SJ, Cases S, Jensen DR, Chen HC, Sande E, Tow B, Sanan DA, Raber J, Eckel RH, Farese RV Jr.

Nat Genet. 2000 May;25(1):87-90.

PMID:
10802663
8.

Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1.

Accad M, Smith SJ, Newland DL, Sanan DA, King LE Jr, Linton MF, Fazio S, Farese RV Jr.

J Clin Invest. 2000 Mar;105(6):711-9.

9.
10.

Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).

Sanan DA, Newland DL, Tao R, Marcovina S, Wang J, Mooser V, Hammer RE, Hobbs HH.

Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4544-9.

11.

Role of actin-binding protein in insertion of adhesion receptors into the membrane.

Meyer SC, Sanan DA, Fox JE.

J Biol Chem. 1998 Jan 30;273(5):3013-20.

12.

Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake.

Dichek HL, Brecht W, Fan J, Ji ZS, McCormick SP, Akeefe H, Conzo L, Sanan DA, Weisgraber KH, Young SG, Taylor JM, Mahley RW.

J Biol Chem. 1998 Jan 23;273(4):1896-903.

13.
14.

Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.

Véniant MM, Pierotti V, Newland D, Cham CM, Sanan DA, Walzem RL, Young SG.

J Clin Invest. 1997 Jul 1;100(1):180-8.

15.

Hepatic lipase is abundant on both hepatocyte and endothelial cell surfaces in the liver.

Sanan DA, Fan J, Bensadoun A, Taylor JM.

J Lipid Res. 1997 May;38(5):1002-13.

16.
17.

The platelet cytoskeleton stabilizes the interaction between alphaIIbbeta3 and its ligand and induces selective movements of ligand-occupied integrin.

Fox JE, Shattil SJ, Kinlough-Rathbone RL, Richardson M, Packham MA, Sanan DA.

J Biol Chem. 1996 Mar 22;271(12):7004-11.

18.

Phagosome-lysosome fusion is a calcium-independent event in macrophages.

Zimmerli S, Majeed M, Gustavsson M, Stendahl O, Sanan DA, Ernst JD.

J Cell Biol. 1996 Jan;132(1-2):49-61.

19.

Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.

Bellosta S, Mahley RW, Sanan DA, Murata J, Newland DL, Taylor JM, Pitas RE.

J Clin Invest. 1995 Nov;96(5):2170-9.

20.

Relative contributions of apolipoprotein(a) and apolipoprotein-B to the development of fatty lesions in the proximal aorta of mice.

Mancini FP, Newland DL, Mooser V, Murata J, Marcovina S, Young SG, Hammer RE, Sanan DA, Hobbs HH.

Arterioscler Thromb Vasc Biol. 1995 Nov;15(11):1911-6.

PMID:
7583571
21.
22.
23.

Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.

Purcell-Huynh DA, Farese RV Jr, Johnson DF, Flynn LM, Pierotti V, Newland DL, Linton MF, Sanan DA, Young SG.

J Clin Invest. 1995 May;95(5):2246-57.

25.

Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112,Cys142).

Fazio S, Sanan DA, Lee YL, Ji ZS, Mahley RW, Rall SC Jr.

Arterioscler Thromb. 1994 Nov;14(11):1873-9.

PMID:
7947615
26.

Glycoprotein (GP) Ib beta is the critical subunit linking GP Ib alpha and GP IX in the GP Ib-IX complex. Analysis of partial complexes.

López JA, Weisman S, Sanan DA, Sih T, Chambers M, Li CQ.

J Biol Chem. 1994 Sep 23;269(38):23716-21.

27.

Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.

Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD, et al.

J Clin Invest. 1994 Aug;94(2):860-9.

28.

Association of GP Ib with actin-binding protein does not require GP IX.

López JA, Weisman S, Sih T, Li CQ, Sanan DA.

Blood Coagul Fibrinolysis. 1994 Aug;5(4):479-85.

PMID:
7841302
29.

Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro.

Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE.

Science. 1994 May 6;264(5160):850-2.

PMID:
8171342
30.

Asymptomatic homozygous hypobetalipoproteinemia associated with apolipoprotein B45.2.

Young SG, Bihain B, Flynn LM, Sanan DA, Ayrault-Jarrier M, Jacotot B.

Hum Mol Genet. 1994 May;3(5):741-4.

PMID:
8081360
31.

ApoA-IV is secreted on discrete HDL particles by the rat hepatoma cell line McA-RH7777 transfected with ApoA-IV cDNA.

Yao Z, Lauer SJ, Sanan DA, Fazio S.

Arterioscler Thromb. 1993 Oct;13(10):1476-86.

PMID:
8399085
32.

Reconstitution of clathrin-coated pit budding from plasma membranes.

Lin HC, Moore MS, Sanan DA, Anderson RG.

J Cell Biol. 1991 Sep;114(5):881-91.

33.
34.

Ammonium chloride causes reversible inhibition of low density lipoprotein receptor recycling and accelerates receptor degradation.

Grant KI, Casciola LA, Coetzee GA, Sanan DA, Gevers W, van der Westhuyzen DR.

J Biol Chem. 1990 Mar 5;265(7):4041-7.

35.

Early appearance of dispersed low density lipoprotein receptors on the fibroblast surface during recycling.

Sanan DA, van der Westhuyzen DR, Gevers W, Coetzee GA.

Eur J Cell Biol. 1989 Apr;48(2):327-36.

PMID:
2744006
36.

Defective LDL receptors that are common in a large population. Familial hypercholesterolaemia in South Africa.

Gevers W, Casciola LA, Fourie AM, Sanan DA, Coetzee GA, van der Westhuyzen DR.

Biol Chem Hoppe Seyler. 1987 Oct;368(10):1233-43. Review. No abstract available.

PMID:
3322320
37.
38.
39.

Native and acetylated low density lipoprotein metabolism in proliferating and quiescent bovine endothelial cells in culture.

Sanan DA, Strümpfer AE, van der Westhuyzen DR, Coetzee GA.

Eur J Cell Biol. 1985 Jan;36(1):81-90.

PMID:
3979404

Supplemental Content

Loading ...
Support Center